Literature DB >> 29098880

Specificity of reversible ADP-ribosylation and regulation of cellular processes.

Kerryanne Crawford1, Juan José Bonfiglio2, Andreja Mikoč3, Ivan Matic2, Ivan Ahel1.   

Abstract

Proper and timely regulation of cellular processes is fundamental to the overall health and viability of organisms across all kingdoms of life. Thus, organisms have evolved multiple highly dynamic and complex biochemical signaling cascades in order to adapt and survive diverse challenges. One such method of conferring rapid adaptation is the addition or removal of reversible modifications of different chemical groups onto macromolecules which in turn induce the appropriate downstream outcome. ADP-ribosylation, the addition of ADP-ribose (ADPr) groups, represents one of these highly conserved signaling chemicals. Herein we outline the writers, erasers and readers of ADP-ribosylation and dip into the multitude of cellular processes they have been implicated in. We also review what we currently know on how specificity of activity is ensured for this important modification.

Entities:  

Keywords:  ADP-ribosyl transferase; ADP-ribosylation; ARH3; DNA damage; PARG; PARP; macrodomain; reversible protein modification

Mesh:

Substances:

Year:  2017        PMID: 29098880     DOI: 10.1080/10409238.2017.1394265

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  33 in total

1.  PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.

Authors:  Masato Mashimo; Xiangning Bu; Kazumasa Aoyama; Jiro Kato; Hiroko Ishiwata-Endo; Linda A Stevens; Atsushi Kasamatsu; Lynne A Wolfe; Camilo Toro; David Adams; Thomas Markello; William A Gahl; Joel Moss
Journal:  JCI Insight       Date:  2019-02-21

Review 2.  Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways.

Authors:  Xiangning Bu; Jiro Kato; Joel Moss
Journal:  Biochem Pharmacol       Date:  2018-09-27       Impact factor: 5.858

3.  Q-FADD: A Mechanistic Approach for Modeling the Accumulation of Proteins at Sites of DNA Damage.

Authors:  Jyothi Mahadevan; Johannes Rudolph; Asmita Jha; Jian Wei Tay; Joseph Dragavon; Erik M Grumstrup; Karolin Luger
Journal:  Biophys J       Date:  2019-05-03       Impact factor: 4.033

Review 4.  Poly(ADP-Ribosylation) in Age-Related Neurological Disease.

Authors:  Leeanne McGurk; Olivia M Rifai; Nancy M Bonini
Journal:  Trends Genet       Date:  2019-06-07       Impact factor: 11.639

Review 5.  Research Progress on Mono-ADP-Ribosyltransferases in Human Cell Biology.

Authors:  Yujie Gan; Huanhuan Sha; Renrui Zou; Miao Xu; Yuan Zhang; Jifeng Feng; Jianzhong Wu
Journal:  Front Cell Dev Biol       Date:  2022-05-16

6.  Structural and functional analysis of parameters governing tankyrase-1 interaction with telomeric repeat-binding factor 1 and GDP-mannose 4,6-dehydratase.

Authors:  Travis Eisemann; Marie-France Langelier; John M Pascal
Journal:  J Biol Chem       Date:  2019-08-02       Impact factor: 5.157

7.  Comparative inhibitory profile and distribution of bacterial PARPs, using Clostridioides difficile CD160 PARP as a model.

Authors:  Antonio Ginés García-Saura; Rubén Zapata-Pérez; José Francisco Hidalgo; Álvaro Sánchez-Ferrer
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

Review 8.  PARPs in genome stability and signal transduction: implications for cancer therapy.

Authors:  Luca Palazzo; Ivan Ahel
Journal:  Biochem Soc Trans       Date:  2018-11-12       Impact factor: 5.407

Review 9.  PARP inhibitors in gastric cancer: beacon of hope.

Authors:  Yali Wang; Kun Zheng; Yongbiao Huang; Hua Xiong; Jinfang Su; Rui Chen; Yanmei Zou
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24

10.  Serine is the major residue for ADP-ribosylation upon DNA damage.

Authors:  Luca Palazzo; Orsolya Leidecker; Evgeniia Prokhorova; Helen Dauben; Ivan Matic; Ivan Ahel
Journal:  Elife       Date:  2018-02-26       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.